Literature DB >> 18446425

Nobel Prizes and the emerging virus concept.

Erling Norrby1.   

Abstract

The existence of infectious agents smaller than bacteria was demonstrated already during the 1890s. After this discovery it took more than 50 years before a resilient definition of viruses could be given. There were separate developments of knowledge concerning plant viruses, bacterial viruses and animal viruses. In the mid-1930s, Wendell Stanley at the Rockefeller Institute for Medical Research at Princeton described the purification and crystallization of tobacco mosaic virus. The finding of an "infectious protein" led to him receiving a Nobel Prize in Chemistry in 1946. In studies initiated at the end of the 1930s, bacteriophages were used as a model for replicating genes. They led to important insights into the unique characteristics of virus-cell interactions. However, an understanding of the chemical nature of animal virus particles and their mode of replication was slow in coming. Not until the early 1950s did tissue culture techniques become available, which allowed studies also of an extended number of animal viruses. This article discusses the emergence of concepts which eventually allowed a description of viruses. The unique real-time analyses of the state of knowledge provided by the Nobel Prize archives were used in the investigation. These archives remain secret for 50 years. Besides all of the underlying documents of the Prize to Stanley, comprehensive investigations made in the mid 1950s of Seymour E. Cohen, Max Delbrück, Alfred D. Hershey and Salvador D. Luria (the latter three received a Prize in Medicine in 1969) and of André Lwoff (he shared a Prize in Medicine with Francois Jacob and Jaques Monod in 1965) were reviewed. The final phase of the evolution of our understanding of the virus concept closely paralleled the eventual insight into the chemical nature of the genetic material. Understanding the principle nature of barriers to the development of new concepts is of timeless value for fostering and facilitating new discoveries in science.

Entities:  

Mesh:

Year:  2008        PMID: 18446425     DOI: 10.1007/s00705-008-0088-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

Review 1.  Bacteriophage resistance mechanisms.

Authors:  Simon J Labrie; Julie E Samson; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

2.  Making a Virus Visible: Francis O. Holmes and a biological assay for tobacco mosaic virus.

Authors:  Karen-Beth G Scholthof
Journal:  J Hist Biol       Date:  2014       Impact factor: 1.326

Review 3.  Viral Infections, the Microbiome, and Probiotics.

Authors:  Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day
Journal:  Front Cell Infect Microbiol       Date:  2021-02-12       Impact factor: 6.073

Review 4.  Archaeal viruses, not archaeal phages: an archaeological dig.

Authors:  Stephen T Abedon; Kelly L Murray
Journal:  Archaea       Date:  2013-04-07       Impact factor: 3.273

Review 5.  Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma.

Authors:  Urszula Hibner; Damien Grégoire
Journal:  Contemp Oncol (Pozn)       Date:  2015

6.  A thermodynamic insight into viral infections: do viruses in a lytic cycle hijack cell metabolism due to their low Gibbs energy?

Authors:  Marko Popovic; Mirjana Minceva
Journal:  Heliyon       Date:  2020-05-08

7.  BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes.

Authors:  Laura J Marinelli; Mariana Piuri; Zuzana Swigonová; Amrita Balachandran; Lauren M Oldfield; Julia C van Kessel; Graham F Hatfull
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

Review 8.  Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies.

Authors:  Claudia Koch; Fabian J Eber; Carlos Azucena; Alexander Förste; Stefan Walheim; Thomas Schimmel; Alexander M Bittner; Holger Jeske; Hartmut Gliemann; Sabine Eiben; Fania C Geiger; Christina Wege
Journal:  Beilstein J Nanotechnol       Date:  2016-04-25       Impact factor: 3.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.